Relay Therapeutics
RLAY
RLAY
172 hedge funds and large institutions have $1.1B invested in Relay Therapeutics in 2023 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 67 increasing their positions, 47 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.23% less ownership
Funds ownership: 107.05% → 106.82% (-0.23%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
33% less capital invested
Capital invested by funds: $1.64B → $1.1B (-$541M)
Holders
172
Holding in Top 10
3
Calls
$195K
Puts
$106K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$7.78M | |
| 3 | +$6.01M | |
| 4 |
O
OrbiMed
New York
|
+$4.22M |
| 5 |
Two Sigma Investments
New York
|
+$3.37M |
Top Sellers
| 1 | -$19.4M | |
| 2 | -$15.2M | |
| 3 | -$7.14M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$6.35M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$5.29M |